VACH
Voyager Acquisition Corp./Cayman Islands—
Short interest
1.4K
−19.1%
Days to cover
1.0
at average volume
SecBot read BEARISH 2 reports · latest
Balance 2 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 2/2
Price
Daily candles with volume.
No data for this timeframe.
Signal stack
Where each data set points today.
- Short sellersCOVERING
Short interest −19.1% to 1.4K shares. 1.0 days to cover.
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 12, 2026 Earnings calendar
Mar 13, 2026 Press VACH Q2 2026 Earnings Scheduled — 2026-08-12
Voyager Acquisition Corp. (VACH) has approved its business combination with VERAXA Biotech AG, with 99.67% of…
Impact 8/10
Voyager Acquisition Corp. completed its business combination with VERAXA Biotech AG, but approximately 99.67% of…
Impact 8/10
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
Short side
FINRA· May 29, 20261,387
shares short
-19.1%
vs prior settlement
1.0
days to cover
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Aug 12, 2026
Earnings date
VACH Q2 2026 Earnings Scheduled — 2026-08-12
May 13, 2026
Earnings date
VACH Q1 2026 Earnings Scheduled — 2026-05-13
Mar 30, 2026
Earnings date
VACH Q4 2025 Earnings Scheduled — 2026-03-30
Mar 13, 2026
M&A
Voyager Acquisition Corporation Announces Approval of Its Business Combination with Veraxa Biotech AG
BROOKLYN, N.Y., March 13, 2026 (GLOBE NEWSWIRE) -- Voyager Acquisition Corporation (NASDAQ: “VACHU,” “VACH,” “VACHW”) (“Voyager” or the “Company”)…
Mar 11, 2026
M&A
Voyager Acquisition Corporation Announces Redemption Results in Connection with its Business Combination with VERAXA Biotech AG
BROOKLYN, N.Y., March 11, 2026 (GLOBE NEWSWIRE) -- Voyager Acquisition Corporation (NASDAQ: “VACHU,” “VACH,” “VACHW”) (“Voyager” or the “Company”)…
SecBot reports
- BEARISH PRESS RELEASEMar 13, 2026
Voyager Acquisition Corp. (VACH) has approved its business combination with VERAXA Biotech AG…
The extreme redemption rate signals strong investor rejection of VERAXA as a target. Traders should watch for low float dynamics and potential volatility upon listing as VRXA, with high risk of weak…
- BEARISH PRESS RELEASEMar 11, 2026
Voyager Acquisition Corp. completed its business combination with VERAXA Biotech AG, but…
Monitor the post-combination stock performance under the new ticker VRXA; the minimal remaining cash and tiny float suggest high volatility and limited institutional interest. Consider this a de…
All VACH filing & press-release reports (2)
- PRESS-RELEASE reportMar 13, 2026
- PRESS-RELEASE reportMar 11, 2026